Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country

Giannina Izquierdo*, Juan Pablo Torres, M. Elena Santolaya, M. Teresa Valenzuela, Jeannette Vega, May Chomali

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country'. Together they form a unique fingerprint.

Medicine & Life Sciences